mTORC1 hyperactivation in lymphangioleiomyomatosis leads to ACE2 upregulation in type II pneumocytes: implications for COVID-19

Yan Tang, David J. Kwiatkowski, Elizabeth P. Henske

Source: Eur Respir J, 57 (2) 2002737; 10.1183/13993003.02737-2020
Journal Issue: February

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yan Tang, David J. Kwiatkowski, Elizabeth P. Henske. mTORC1 hyperactivation in lymphangioleiomyomatosis leads to ACE2 upregulation in type II pneumocytes: implications for COVID-19. Eur Respir J, 57 (2) 2002737; 10.1183/13993003.02737-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Angiotensin II and hypoxia synergistically induce proliferation in pulmonary artery fibroblasts by a PI-3K and PKC-signaling pathway through HIF-1 a and upregulation of angiotensin II-receptors type I
Source: Eur Respir J 2002; 20: Suppl. 38, 378s
Year: 2002

Overexpression of angiotensin II type 1 receptor (AGTR1) and lymphatic vasculature rarefaction is present in scleroderma with pulmonary compromised
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012

Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes
Source: ERJ Open Res, 7 (2) 00713-2020; 10.1183/23120541.00713-2020
Year: 2021



Signal transduction pathways of the interaction of SP-A with its receptor on rat type II pneumocytes
Source: Eur Respir J 2001; 18: Suppl. 33, 476s
Year: 2001

Autocrine secretion of bradykinin prevents alveolar type II cells from mechanical stretch-induced apoptosis by activation – role of PI3K and Akt
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008


Influence of protein kinase C on stretch-induced apoptosis in rat alveolar type II cells
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012

Evidence of type II pneumocyte apoptosis in the murine model of Hermansky-Pudlak-syndrome associated interstitial pneumonia
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008

Angiotensin II activates the hypoxia-responsive-element (HRE) in human alveolar epithelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 79s
Year: 2001

Cross-talk between TGFbeta and angiotensin II signalling in lung fibroblast-induced collagen matrix contraction
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009


Inhibition of bradykinin breakdown by ACE inhibitors reduces mechanical stretch-induced apoptosis of alveolar type II cells
Source: Eur Respir J 2005; 26: Suppl. 49, 345s
Year: 2005

Imbalanced expression of the type I TGF-beta receptors ALK-1 in pulmonary fibrosis
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009

Decreased expression of the TGF-beta type I receptor ALK1 in pulmonary arterial hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007


Effect of hypoxia on gene regulation and differentiation in alveolar epithelial type II cells
Source: Eur Respir J 2001; 18: Suppl. 33, 162s
Year: 2001

Wnt11 inhibits epithelial-mesenchymal transition induced by TGFb1 in human type II alveolar epithelial cells
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012


Role of TGF-b1 in type I collagen production in bronchial epithelial cells: effects on Smad7 inhibitory role?
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008


mTOR signalling is an essential pathway for TGF-β1 induced collagen synthesis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

The role of cell lines in modelling the type II pneumocyte in interstitial lung disease
Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease
Year: 2020


Proliferation of alveolar type II pneumocytes is stimulated by Jagged-1 in vitro
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012


The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes
Source: Eur Respir Mon; 2009: 46: 47–66
Year: 2009

High concentrations of VEGF reduce stretch-induced apoptosis of alveolar type II cells
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009